NCT06440382

Brief Summary

To identify important ethnic inequalities in cervical cancer screening participation in Scotland, and explore possible reasons for these.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 21, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
Last Updated

June 3, 2024

Status Verified

February 1, 2020

Enrollment Period

3.4 years

First QC Date

May 21, 2024

Last Update Submit

May 27, 2024

Conditions

Cervical Cancer

Outcome Measures

Primary Outcomes (1)

  • % women who attend cervical screening

    within 6 months of date of invitation

Study Arms (2)

screening invitees

eligible women in Scotland invited to cervical screening

interview study

50 women from diverse ethnic groups

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

women (aged 20 to 70) who were living in Scotland in April 2011 and took part in the 2011 Scottish census, and who were invited to participate in the Scottish Cervical Screening Programme between January 2012 and December 2018

You may qualify if:

  • screening invitees through national programme

You may not qualify if:

  • not invited to cervical screening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Edinburgh

Edinburgh, United Kingdom

Location

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2024

First Posted

June 3, 2024

Study Start

March 1, 2019

Primary Completion

August 1, 2022

Study Completion

December 31, 2022

Last Updated

June 3, 2024

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations

GB(1)